translated from Spanish: University of Oxford announced that it will resume vaccine tests against AstraZeneca Covid-19

Oxford University said Saturday that it will resume testing of a vaccine it is developing with pharmaceutical company AstraZeneca, days after putting it on hold when a patient in the UK reported a side effect. The university said in a statement that large tests like this “some participants are expected to suffer from disorders and it is necessary to carefully evaluate each case to ensure safety.” He said some 18,000 people worldwide have received the vaccine as test participants. While she refused to disclose information about the patient’s illness for confidentiality reasons, an AstraZeneca spokesman said the woman exhibited severe neurological symptoms that forced the tests to be paused. The University insisted that it is “committed to the safety of our participants and the highest standards of conduct and will continue to closely monitor safety.” Breaks in drug testing are common. The study had stopped in July when the participant exhibited neurological symptoms: it turned out to be a case of multiple sclerosis unrelated to the vaccine. At the end of last month, AstraZeneca began recruiting 30,000 people for further study of the vaccine. He is also rehearsing it with thousands of people in Britain and conducting smaller studies in Brazil and South Africa.Dr. Soumya Swaminathan, chief scientist of the World Health Organization said that the pause in the Oxford and AstraZeneca test did not worry her too much and that “a call of attention” to the global community about the inevitable ups and downs of medical research.

Original source in Spanish